BioCardia presents CardiAMP HF II trial design at HFSA meeting
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
01:01:38 PM UTC
SquawkNews
BioCardia announced the CardiAMP HF II trial design and said FDA recently agreed the ongoing study may be sufficient to support approval. The poster will be presented at HFSA 2026.Material DetailsContext by AI AnalystThis is a mid-cycle regulatory update indicating potential sufficiency of the ongo…
01:03:17 PM UTC
SquawkNews
BioCardia presented the CardiAMP HF II trial design at HFSA and noted FDA agreement that the trial may be sufficient to support approval.Key Highlights:Original SEC Filing: BioCardia, Inc. [ BCDA ] - 8-K - Oct. 07, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying i…